Bougainville Ventures Inc. Appoints Mr. Andy Dhaliwal, President of Thrive Nutrition to Vice President of Sales and Distribut...
BOUGAINVILLE VENTURES INC. (CSE: BOG)
(FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Bougainville" or the
is pleased to announce that further to the
signing of the definitive agreement to complete the acquisition of
Thrive Nutrition Products Ltd. ("Thrive Wellness") announced in the
Company news release dated September 24, 2019, the Company has
appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice
President of Sales and Distribution for Bougainville Ventures
Inc. Thrive Wellness is a preeminent distributor of hemp
& cannabinoid-focused natural health products under the "THRIVE
About Thrive Nutrition Products Ltd.Thrive
Wellness is a distributor of premium hemp and natural health
products with operations currently in Canada and the USA. Thrive
specializes in the development, marketing and distribution of
cannabinoid products refined into their own natural health product
brand. The company was founded in Vancouver, British Columbia and
is the first of its kind with national retail distribution in
Canada. Thrive has achieved $2,500,000 CDN in sales through retail
distribution, its' e-commerce website and their relationship with
Nutrition House, Canada's leading Natural Health Product franchise.
Founded in 1979 the company began franchising in 1993 and now
operates over 45 retail stores, located in high profile shopping
centers across Canada, and in the
CEO, Andy Dhaliwal Comments:
"I am very excited to be a joining a team that is extremely well
positioned for significant growth in the emerging cannabis &
hemp markets. I look forward to helping Bougainville continue
building shareholder value and to increase our international
exposure through this partnership. I am particularly keen on the
CBD opportunity in the U.S., where Bougainville already has
Mr. Dhaliwal is a pioneering expert in the marketing of
cannabis, hemp, and natural health products, and brings over 12
years of experience in the industry. In addition to serving as the
CEO of Thrive Wellness, he was an advisor for the Province of
British Columbia’s Cannabis Operations, where he advised on
corporate development and sales optimization.
To learn more about what this news means to the shareholders
as well as on the company's site.
About the CBD Market
Bank of America projects a spend of $1.3 Billion on CBD in
Canada by 2022, while $1.9 Billion is being spent in the USA
currently, and another $4.4 Billion in Europe this year. Demand for
CBD and Hemp is increasing year over year, with Merrill Lynch
predicting an $11.5 Billion American market by 2032.
About Bougainville Ventures, Inc.
Bougainville Ventures Inc. is dedicated to rapid growth in
production, processing, retail and branding of cannabis and
cannabis related products. Currently the company provides strategic
capital to the thriving cannabis cultivation sector through
ownership and development of commercial real estate properties. We
offer fully built out turnkey facilities equipped with
state-of-the-art growing infrastructure to cannabis growers and
processors. Also, the Company is focused on building a strong
presence in the hemp industry with the objective of extracting
cannabinoids in both Canada and the United States. Along with our
flagship Hemp project in Oregon State and the Greenhouse campus in
Washington State, the Company has proprietary formulas for cannabis
edibles, topical, and tinctures.
On behalf of the Board of Directors BOUGAINVILLE
Andy Jagpal, President and Director
For further information, please contact Zoltan, IR
604-722-0305 email@example.com. Or
toll free at 1-877-517-7816
FORWARD LOOKING STATEMENTS: This news
release contains certain forward-looking statements within the
meaning of Canadian securities laws. Forward-looking statements are
based on the expectations and opinions of the Company's management
on the date the statements are made. The assumptions used in the
preparation of such statements, although considered reasonable at
the time of preparation, may prove to be imprecise and, as such,
undue reliance should not be placed on forward-looking statements.
The Company expressly disclaims any intention or obligation to
update or revise any forward-looking statements whether as a result
of new information, future events or otherwise.
No regulatory authority has approved or disapproved the
information contained in this news release.